Chih‐Hsiang Leng

1.6k total citations
54 papers, 1.3k citations indexed

About

Chih‐Hsiang Leng is a scholar working on Immunology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Chih‐Hsiang Leng has authored 54 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Immunology, 19 papers in Molecular Biology and 14 papers in Infectious Diseases. Recurrent topics in Chih‐Hsiang Leng's work include Immunotherapy and Immune Responses (23 papers), Immune Response and Inflammation (11 papers) and Mosquito-borne diseases and control (10 papers). Chih‐Hsiang Leng is often cited by papers focused on Immunotherapy and Immune Responses (23 papers), Immune Response and Inflammation (11 papers) and Mosquito-borne diseases and control (10 papers). Chih‐Hsiang Leng collaborates with scholars based in Taiwan, United States and Japan. Chih‐Hsiang Leng's co-authors include Shih‐Jen Liu, Pele Chong, Hsin–Wei Chen, Hsueh‐Hung Liu, Jy-Ping Tsai, Mei‐Yu Chen, Ting‐Fang Wang, Ming‐Hsi Huang, Chen-Yi Chiang and Kuan‐Yin Shen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and The Journal of Immunology.

In The Last Decade

Chih‐Hsiang Leng

54 papers receiving 1.3k citations

Peers

Chih‐Hsiang Leng
Marcin Kwissa United States
Andrés H. Gutiérrez United States
Yunxiang Mu United States
Rinaldo Zurbriggen Switzerland
Champion Deivanayagam United States
Ulrike Wille-Reece United States
Marcin Kwissa United States
Chih‐Hsiang Leng
Citations per year, relative to Chih‐Hsiang Leng Chih‐Hsiang Leng (= 1×) peers Marcin Kwissa

Countries citing papers authored by Chih‐Hsiang Leng

Since Specialization
Citations

This map shows the geographic impact of Chih‐Hsiang Leng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chih‐Hsiang Leng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chih‐Hsiang Leng more than expected).

Fields of papers citing papers by Chih‐Hsiang Leng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chih‐Hsiang Leng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chih‐Hsiang Leng. The network helps show where Chih‐Hsiang Leng may publish in the future.

Co-authorship network of co-authors of Chih‐Hsiang Leng

This figure shows the co-authorship network connecting the top 25 collaborators of Chih‐Hsiang Leng. A scholar is included among the top collaborators of Chih‐Hsiang Leng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chih‐Hsiang Leng. Chih‐Hsiang Leng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Wangxue, et al.. (2023). A broad-spectrum pneumococcal vaccine induces mucosal immunity and protects against lethal Streptococcus pneumoniae challenge. Emerging Microbes & Infections. 12(2). 2272656–2272656. 1 indexed citations
2.
Chiang, Chen-Yi, et al.. (2019). Delivery of Antigen to CD8+ Dendritic Cells by Fusing Antigen With Formyl Peptide Receptor-Like 1 Inhibitor Protein Induces Antitumor Immunity. Frontiers in Immunology. 10. 1839–1839. 10 indexed citations
3.
Chiang, Chen-Yi, et al.. (2018). Efficient Uptake of Recombinant Lipidated Survivin by Antigen-Presenting Cells Initiates Antigen Cross-Presentation and Antitumor Immunity. Frontiers in Immunology. 9. 822–822. 9 indexed citations
4.
Shen, Kuan‐Yin, Hsin‐Yu Liu, Huiju Li, et al.. (2016). A novel liposomal recombinant lipoimmunogen enhances anti-tumor immunity. Journal of Controlled Release. 233. 57–63. 14 indexed citations
5.
Chiang, Chen-Yi, Chien-Hsiung Pan, Mei‐Yu Chen, et al.. (2016). Immunogenicity of a novel tetravalent vaccine formulation with four recombinant lipidated dengue envelope protein domain IIIs in mice. Scientific Reports. 6(1). 30648–30648. 33 indexed citations
7.
Chen, Hsin–Wei, Huimei Hu, Chen-Yi Chiang, et al.. (2015). The Immunodominance Change and Protection of CD4+ T-Cell Responses Elicited by an Envelope Protein Domain III-Based Tetravalent Dengue Vaccine in Mice. PLoS ONE. 10(12). e0145717–e0145717. 16 indexed citations
8.
Song, Ying, Hsueh‐Hung Liu, I‐Hua Chen, et al.. (2014). A Purified Recombinant Lipopeptide as Adjuvant for Cancer Immunotherapy. BioMed Research International. 2014. 1–10. 7 indexed citations
9.
Song, Ying, Hanyin Cheng, Chih‐Hsiang Leng, et al.. (2013). A novel emulsion-type adjuvant containing CpG oligodeoxynucleotides enhances CD8+ T-cell-mediated anti-tumor immunity. Journal of Controlled Release. 173. 158–165. 35 indexed citations
10.
Chiang, Chen-Yi, Chien-Hsiung Pan, Jy-Ping Tsai, et al.. (2013). Lipidated Dengue-2 Envelope Protein Domain III Independently Stimulates Long-Lasting Neutralizing Antibodies and Reduces the Risk of Antibody-Dependent Enhancement. PLoS neglected tropical diseases. 7(9). e2432–e2432. 31 indexed citations
11.
Huang, Chiung‐Yi, Jeremy J.W. Chen, Kuan‐Yin Shen, et al.. (2012). Recombinant Lipidated HPV E7 Induces a Th-1-Biased Immune Response and Protective Immunity against Cervical Cancer in a Mouse Model. PLoS ONE. 7(7). e40970–e40970. 39 indexed citations
12.
Lin, Shih‐Chang, Chih‐Hsiang Leng, & Suh‐Chin Wu. (2010). Generating stable chinese hamster ovary cell clones to produce a truncated SARS‐CoV spike protein for vaccine development. Biotechnology Progress. 26(6). 1733–1740. 3 indexed citations
13.
Huang, Ming‐Hsi, Chiung‐Yi Huang, Ai‐Hsiang Chou, et al.. (2009). Enhancement of potent antibody and T-cell responses by a single-dose, novel nanoemulsion-formulated pandemic influenza vaccine. Microbes and Infection. 11(6-7). 654–660. 15 indexed citations
14.
Huang, Ming‐Hsi, Ai‐Hsiang Chou, Shu‐Pei Lien, et al.. (2009). Formulation and immunological evaluation of novel vaccine delivery systems based on bioresorbable poly(ethylene glycol)‐block‐poly(lactide‐coε‐caprolactone). Journal of Biomedical Materials Research Part B Applied Biomaterials. 90B(2). 832–841. 23 indexed citations
15.
Huang, Ming‐Hsi, Chiung‐Yi Huang, Shu‐Pei Lien, et al.. (2009). Development of Multi-Phase Emulsions Based on Bioresorbable Polymers and Oily Adjuvant. Pharmaceutical Research. 26(8). 1856–1862. 18 indexed citations
16.
Venkatesan, Nandini, Ai‐Hsiang Chou, Hsin–Wei Chen, et al.. (2009). Immunological study of HA1 domain of hemagglutinin of influenza H5N1 virus. Biochemical and Biophysical Research Communications. 383(1). 27–31. 39 indexed citations
17.
Chen, Hsin–Wei, Shih‐Jen Liu, Hsueh‐Hung Liu, et al.. (2009). A novel technology for the production of a heterologous lipoprotein immunogen in high yield has implications for the field of vaccine design. Vaccine. 27(9). 1400–1409. 62 indexed citations
18.
Hanying, Sun, Su‐Ming Hu, Ching‐Feng Chiu, et al.. (2008). An improved SUMO fusion protein system for effective production of native proteins. Protein Science. 17(7). 1241–1248. 103 indexed citations
19.
Tsao, Yeou‐Ping, Jianyu Lin, Jia‐Tsrong Jan, et al.. (2006). HLA-A∗0201 T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus nucleocapsid and spike proteins. Biochemical and Biophysical Research Communications. 344(1). 63–71. 45 indexed citations
20.
Lee, Ming‐Hui, Chih‐Hsiang Leng, Yuan‐Chih Chang, et al.. (2004). Self-polymerization of archaeal RadA protein into long and fine helical filaments. Biochemical and Biophysical Research Communications. 323(3). 845–851. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026